Total Funding
9
17
Total FundingDebt Financing raised
Growth Score 9 in past quarter
-9 pts
Heat Score 17 in past quarter
8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
503652
Planet Biotechnology is a clinical-stage company that develops monoclonal antibody-based therapeutic and preventative products.
- Elliott Fineman: President and CEO
- James W. Larrick: Vice President and Chief Technical Officer
About the Company
PLANET BIOTECHNOLOGY INCORPORATED is a clinical stage company. We discover, develop and commercialize new monoclonal-antibody-based therapeutic and preventative products to meet significant underserved medical needs. Our unique antibody-based products are produced through cultivation of genetically modified green plants.
